Safety and Immunogenicity Study of a Dengue Virus DNA Vaccine

NCT00290147 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

FED

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: D1ME100 (dengue-1 premembrane/envelope DNA vaccine)

Sponsor

U.S. Army Medical Research and Development Command

Collaborators

[object Object]